Recon: Lilly scores approval for next-gen type 2 diabetes drug; FDA&...

05/16/22

Recon: Lilly scores approval for next-gen type 2 diabetes drug; FDA's RWE pilot cites challenges in emulating RCTs Regulatory Focus

[more]

Feeds Categories: